NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku) announced today that the U.S. Food and Drug Administration has accepted for review the Biologics License ...

This drugmaker achieved a milestone - its first quarterly profit. But the stock is down despite the good tidings.

Priceless Water Wells today announced that it is changing its name to Flowcore, effective . This strategic rebranding reflects the company's evolution, expanded service offerings, and commitment to ...

Leading Exosome Biotechnology Company Advances in Global Effort to Extend Healthy Human Lifespan MIRAMAR, Fla., May 12, 2025 ...

Addition of commercial-scale sterile injectables capabilities in Lexington, KYAddition of development and commercial-scale ...

As of March 31, 2025, the Company’s cash, cash equivalents and investments was $314.2 million. The Company expects that its cash, cash equivalents and investments, as of March 31, 2025, will fund its ...

President Donald Trump unwrapped a massive drug pricing policy as CMS prepares for the next round of Medicare drug price ...

WASHINGTON, D.C.—FDA Commissioner Martin Makary, M.D., offered more details into the agency’s recently announced plans to ...

WuXi Biologics ("WuXi Bio"), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced the successful completion of the first commercial project Process ...